Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resisted a class of drugs called ...
The Financial Conduct Authority (FCA) is set to become the anti-money laundering (AML) and counter-terrorism financing (CTF) ...
Coinbase bought the UpOnly NFT for $25 million, enabling it to make Cobie “perform like a monkey” in a revival of the ...
By combining proteasome inhibitors with a second drug that disables one of two backup survival pathways, the team was able to ...
Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics October 16, ...
Retail Banker International on MSN
Money laundering costs $5.5tn across the globe: Napier AI
Napier AI’s 2025/26 global AML Index, researched by Napier AI in partnership with Global Data, ranks 40 global markets based ...
IDH1 mutations in MDS are crucial for guiding therapy decisions, offering one of the few targetable mutations in this disease ...
Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML - ...
Addition of TUS to VEN+AZA achieves CR/CRh responses in all (6/6, 100%) patients treated at the higher dose levels of 80 mg and 120 mg TUS, ...
- KOMET-001 in R/R NPM1-m AML met its primary endpoint with ziftomenib monotherapy demonstrating significant clinical benefit and deep responses - - Consistent activity across pre-specified subgroups, ...
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – – FLT3 mutations occur in approximately 30% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback